• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第三代用于抗癌光动力治疗的光敏剂的特点:综述。

Features of third generation photosensitizers used in anticancer photodynamic therapy: Review.

机构信息

São Carlos Institute of Physics, University of São Paulo, 13566-590, São Carlos, Brazil.

São Carlos Institute of Physics, University of São Paulo, 13566-590, São Carlos, Brazil.

出版信息

Photodiagnosis Photodyn Ther. 2021 Jun;34:102091. doi: 10.1016/j.pdpdt.2020.102091. Epub 2021 Jan 13.

DOI:10.1016/j.pdpdt.2020.102091
PMID:33453423
Abstract

Cancer remains a main public health issue and the second cause of mortality worldwide. Photodynamic therapy is a clinically approved therapeutic option. Effective photodynamic therapy induces cancer damage and death through a multifactorial manner including reactive oxygen species-mediated damage and killing, vasculature damage, and immune defense activation. Anticancer efficiency depends on the improvement of photosensitizers drugs used in photodynamic therapy, their selectivity, enhanced photoproduction of reactive species, absorption at near-infrared spectrum, and drug-delivery strategies. Both experimental and clinical studies using first- and second-generation photosensitizers had pointed out the need for developing improved photosensitizers for photodynamic applications and achieving better therapeutic outcomes. Bioconjugation and encapsulation with targeting moieties appear as a main strategies for the development of photosensitizers from their precursors. Factors influencing cellular biodistribution and uptake are briefly discussed, as well as their roles as cancer diagnostic and therapeutic (theranostics) agents. The two-photon photodynamic approach using third-generation photosensitizers is present as an attempt in treating deeper tumors. Although significant advances had been made over the last decade, the development of next-generation photosensitizers is still mainly in the developmental stage.

摘要

癌症仍然是一个主要的公共卫生问题,也是全球死亡的第二大原因。光动力疗法是一种临床认可的治疗选择。有效的光动力疗法通过多种因素诱导癌症损伤和死亡,包括活性氧介导的损伤和杀伤、血管损伤和免疫防御激活。抗癌效率取决于光动力疗法中使用的光敏剂药物的改进、其选择性、增强活性物质的光生产、近红外光谱吸收和药物输送策略。使用第一代和第二代光敏剂的实验和临床研究都指出,需要开发用于光动力应用的改良光敏剂,以获得更好的治疗效果。生物共轭和靶向基团的封装似乎是从其前体开发光敏剂的主要策略。简要讨论了影响细胞生物分布和摄取的因素,以及它们作为癌症诊断和治疗(治疗学)剂的作用。使用第三代光敏剂的双光子光动力方法是治疗深部肿瘤的一种尝试。尽管在过去十年中取得了重大进展,但下一代光敏剂的开发仍主要处于发展阶段。

相似文献

1
Features of third generation photosensitizers used in anticancer photodynamic therapy: Review.第三代用于抗癌光动力治疗的光敏剂的特点:综述。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102091. doi: 10.1016/j.pdpdt.2020.102091. Epub 2021 Jan 13.
2
Development of Novel Tetrapyrrole Structure Photosensitizers for Cancer Photodynamic Therapy.用于癌症光动力疗法的新型四吡咯结构光敏剂的研发
Bioengineering (Basel). 2022 Feb 19;9(2):82. doi: 10.3390/bioengineering9020082.
3
Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.无重金属原子的光敏剂:从分子设计到癌症光动力疗法中的应用。
Acc Chem Res. 2021 Jan 5;54(1):207-220. doi: 10.1021/acs.accounts.0c00606. Epub 2020 Dec 8.
4
Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.脂质体光敏剂:用于抗癌光动力疗法的潜在平台。
Braz J Med Biol Res. 2011 Aug;44(8):729-37. doi: 10.1590/s0100-879x2011007500091.
5
Recent Advances in the HPPH-Based Third-Generation Photodynamic Agents in Biomedical Applications.基于 HPPH 的第三代光动力试剂在生物医学应用中的最新进展。
Int J Mol Sci. 2023 Dec 12;24(24):17404. doi: 10.3390/ijms242417404.
6
Recent Photosensitizer Developments, Delivery Strategies and Combination-based Approaches for Photodynamic Therapy.光动力疗法的近期光敏剂进展、递送策略及基于联合治疗的方法
Photochem Photobiol. 2023 Mar;99(2):469-497. doi: 10.1111/php.13749. Epub 2022 Dec 20.
7
Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy.用于光动力癌症治疗的光敏剂开发的最新进展
Comb Chem High Throughput Screen. 2017;20(5):414-422. doi: 10.2174/1386207320666170113123132.
8
Liposomes for photodynamic therapy.用于光动力疗法的脂质体
Adv Drug Deliv Rev. 2004 Jan 13;56(1):17-30. doi: 10.1016/j.addr.2003.07.014.
9
Photosensitizers for Photodynamic Therapy.光动力疗法光敏剂。
Adv Healthc Mater. 2019 Jul;8(13):e1900132. doi: 10.1002/adhm.201900132. Epub 2019 May 8.
10
Therapeutic Considerations and Conjugated Polymer-Based Photosensitizers for Photodynamic Therapy.治疗考虑因素和用于光动力疗法的共轭聚合物光敏剂。
Macromol Rapid Commun. 2018 Mar;39(5). doi: 10.1002/marc.201700614. Epub 2017 Dec 18.

引用本文的文献

1
Obtention and Characterization of TiO-Folic Acid-ZnPc Semiconductor Nanoparticles for Photodynamic Therapy Against Glioma Cells.用于抗胶质瘤细胞光动力治疗的TiO-叶酸-ZnPc半导体纳米颗粒的制备与表征
Pharmaceutics. 2025 Aug 19;17(8):1071. doi: 10.3390/pharmaceutics17081071.
2
Research landscape of photodynamic therapy for hepatocellular carcinoma: Hotspots and Prospects from 2012 to 2025.肝细胞癌光动力疗法的研究概况:2012年至2025年的热点与展望
Hereditas. 2025 Aug 26;162(1):174. doi: 10.1186/s41065-025-00509-1.
3
Advancements and emerging trends in photodynamic therapy: innovations in cancer treatment and beyond.
光动力疗法的进展与新兴趋势:癌症治疗及其他领域的创新
Photochem Photobiol Sci. 2025 Jul 24. doi: 10.1007/s43630-025-00765-0.
4
Light-activated multimodal nanoplatform for enhanced synergistic therapy of breast cancer.用于增强乳腺癌协同治疗的光激活多模态纳米平台。
Sci Rep. 2025 Jul 17;15(1):25995. doi: 10.1038/s41598-025-11165-w.
5
Antimicrobial Photodynamic Therapy for Superficial, Skin, and Mucosal Fungal Infections: An Update.浅表、皮肤及黏膜真菌感染的抗菌光动力疗法:最新进展
Microorganisms. 2025 Jun 17;13(6):1406. doi: 10.3390/microorganisms13061406.
6
Formulation and Characterization of Carbopol-Based Porphyrin Gels for Targeted Dermato-Oncological Therapy: Physicochemical and Pharmacotechnical Insights.用于靶向皮肤肿瘤治疗的卡波姆基卟啉凝胶的配方与表征:物理化学和药剂学见解
Int J Mol Sci. 2025 Apr 11;26(8):3641. doi: 10.3390/ijms26083641.
7
The Combination of Active-Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment.主动靶向光动力疗法与光活化化疗联合用于增强癌症治疗
J Biophotonics. 2025 Jun;18(6):e70005. doi: 10.1002/jbio.70005. Epub 2025 Mar 14.
8
Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy.基于植物化学物质的纳米系统:抗病毒光动力疗法的最新进展与新兴应用
Nanomedicine (Lond). 2025 Feb;20(4):401-416. doi: 10.1080/17435889.2025.2452151. Epub 2025 Jan 23.
9
The optimization and application of photodynamic diagnosis and autofluorescence imaging in tumor diagnosis and guided surgery: current status and future prospects.光动力诊断和自体荧光成像在肿瘤诊断及引导手术中的优化与应用:现状与未来展望
Front Oncol. 2025 Jan 8;14:1503404. doi: 10.3389/fonc.2024.1503404. eCollection 2024.
10
Ce6-GFFY is a novel photosensitizer for colorectal cancer therapy.Ce6-GFFY是一种用于结直肠癌治疗的新型光敏剂。
Genes Dis. 2024 Oct 28;12(2):101441. doi: 10.1016/j.gendis.2024.101441. eCollection 2025 Mar.